Spirobarbital

Spirobarbital is a barbiturate derivative developed by Eli Lilly in the 1940s.[1] It has hypnotic and sedative effects, and has a moderate potential for abuse.[2]

Spirobarbital
Clinical data
Other names5-spiro-(2'-ethyl-3'-5'-dimethyl-cyclopentyl)barbituric acid
ATC code
  • none
Identifiers
CAS Number
UNII
Chemical and physical data
FormulaC12H18N2O3
Molar mass238.282 g/mol g·mol−1
3D model (JSmol)
  (verify)

References
  1. US Patent 2561688
  2. Isbell H, Chrusciel TS. Dependence Liability of Non-Narcotic Drugs. Bulletin of the World Health Organization 1970; 43: Supplement.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.